Abdel Motal U M, Zhou X, Joki A, Siddiqi A R, Srinivasa B R, Stenvall K, Dahmén J, Jondal M
Department of Immunology, Karolinska Institute, Stockholm, Sweden.
Eur J Immunol. 1993 Dec;23(12):3224-9. doi: 10.1002/eji.1830231227.
Cytotoxic T lymphocytes (CTL) recognize target antigens as short, processed peptides bound to major histocompatibility complex class I (MHC-I) heavy and light chains (beta 2-microglobulin; beta 2-m). The heavy chain, which comprise the actual peptide binding alpha-1 and alpha-2 domains, can exist at the cell surface in different forms, either free, bound to beta 2-m or as a ternary complex with beta 2-m and peptides. MHC-I chains are also known to internalize, and recycle to the cell surface, and this has been suggested to be important in peptide presentation. Whether MHC-I-bound peptides also can recycle is not known. We have investigated this by using both peptide transporter mutant RMA-S cells and EL4 cells loaded with Db-binding peptides, by two different approaches. First, peptides were covalently linked with galabiose (Gal alpha 4Gal) at a position which did not interfere with Db binding or immunogenicity, and peptide recycling tested with Gal2-specific monoclonal antibodies. By flow cytometry, a return of Gal2 epitopes to the cell surface was found, after cellular internalization and cell surface clearance by pronase treatment. This peptide recycling could be discriminated from free fluid-phase uptake and was inhibited by methylamine, chloroquine and low temperature (18 degrees C) but not by leupeptin. Second, specific CTL were reacted with peptide-loaded target cells after complete removal of surface Db molecules by pronase, and after different times of incubation at 37 degrees C to allow reexpression. By this procedure, reappearance of target cell susceptibility was confirmed. The results are in agreement with a model for optimizing peptide presentation by recycling through an intracellular compartment similar to early endosomes in certain antigen-presenting cells.
细胞毒性T淋巴细胞(CTL)将靶抗原识别为与主要组织相容性复合体I类(MHC-I)重链和轻链(β2-微球蛋白;β2-m)结合的短加工肽段。重链包含实际的肽结合α-1和α-2结构域,可在细胞表面以不同形式存在,要么游离,要么与β2-m结合,要么作为与β2-m和肽的三元复合物存在。已知MHC-I链会内化并循环回到细胞表面,这被认为在肽呈递中很重要。尚不清楚与MHC-I结合的肽是否也能循环。我们通过两种不同方法,利用肽转运体突变体RMA-S细胞和加载了Db结合肽的EL4细胞对此进行了研究。首先,将肽在不干扰Db结合或免疫原性的位置与半乳糖(Galα4Gal)共价连接,并用Gal2特异性单克隆抗体测试肽的循环。通过流式细胞术发现,在细胞内化并用链霉蛋白酶处理清除细胞表面后,Gal2表位回到了细胞表面。这种肽循环可以与游离液相摄取区分开来,并受到甲胺、氯喹和低温(18℃)的抑制,但不受亮抑酶肽的抑制。其次,在用链霉蛋白酶完全去除表面Db分子后,让特异性CTL与负载肽的靶细胞反应,并在37℃孵育不同时间以允许其重新表达。通过该程序,证实了靶细胞敏感性的再现。结果与通过类似于某些抗原呈递细胞中早期内体的细胞内区室循环来优化肽呈递的模型一致。